Transdel Pharmaceuticals, Inc. (HROW)

Last Year

25-Apr-23 -- 24-Apr-24

Time Period:

$261.56K Net Amount

Buy:	$261.56K	$8.03 - $8.11
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

17

0

3

+1

1

+2

0

+3

Two Year Chart

25-Apr-22 -- 24-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
25-Mar-24 7:00 AM View:	22-Mar-24 Purchase $104.31K	Baum Mark L Chief Executive Officer Director		Transdel Pharmaceuticals, Inc. - HROW	38% 1.55M to 2.14M	$60.82K	0	$8.11	--	Show Txns Hide Txns

21-Feb-24 7:29 PM View:	20-Feb-24 Option Exercise $197.18K	Boll Andrew Chief Financial Officer		Transdel Pharmaceuticals, Inc. - HROW	75% 324.02K to 568.09K	0	0	--	--	Show Txns Hide Txns

Today 4:40 PM View:	Today Purchase $84.09K	Opaleye Management Inc. 10% Owner		Transdel Pharmaceuticals, Inc. - HROW	5% 3.6M to 3.79M	$200.74K 1%	0	$8.03	--	Show Txns Hide Txns

15-Aug-23 7:30 AM View:	14-Aug-23 Purchase $338.40K	Makary Martin A. Director		Transdel Pharmaceuticals, Inc. - HROW	80% 25.0K to 45.0K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 6:06 AM View:	01-Mar-24 Option Exercise $43.75K	Saharek John P. CEO of ImprimisRx		Transdel Pharmaceuticals, Inc. - HROW	371% 54.08K to 254.8K	0	0	--	--	Show Txns Hide Txns